Prognostic factors of colorectal cancer based on weibull distribution with nonconstant shape

authors:

avatar Haleh Aghamolaey , avatar Ahmad Reza Baghestani ORCID , * , avatar Farid Zayeri , avatar Soraya Moamer

Koomesh: Vol.20, issue 4; 645-649
published online: March 09, 2018
article type: issue_documents_importer
received: May 02, 2017
accepted: April 09, 2018

how to cite: Aghamolaey H, Baghestani A R, Zayeri F, Moamer S. Prognostic factors of colorectal cancer based on weibull distribution with nonconstant shape. koomesh. 2018;20(4):e153006. 

Abstract

Introduction: The commonest malignant cancer in the lower gastrointestinal tract is colorectal cancer which is the third cause of death due to cancer in the world. The incidence of this type of cancer in Iran has increased during last recent years. The prsent study aimed to detemine prognostic factors of colorectal cancer based on weibull distribution with nonconstant shape. Materials and Methods: In this article we analyzed survival of 1060 patients with colorectal cancer who registered in Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences (Tehran, Iran) from 2004 to 2015. Weilbull parametric model with non-constant shape parameter were used for determination of prognostic factors. The results were compared to regular Weibull distribution and the best method were choosed based on AIC criteria. Results: On constant shape parameter, age at diagnosis, tumor size and the tumor site had effect on survival time with AIC of 20037. On non-constant shape parameter, sex, age at diagnosis, tumor size, the tumor site and the body mass index were significant on survival of these patients with AIC of 19994. Conclusion: Remarkably, based on these data and AIC criteria, the Weibull with non-constant shape parameter chose so that sex, age at diagnosis, tumor size, the tumor site and the body mass index of these patients were recognized as prognostic factors in their survival

References

  • 1.

    Chan KK, Dassanayake B, Deen R, Wickramarachchi RE, Kumarage SK, Samita S, Deen KI. Young patients with colorectal cancer have poor survival in the first twenty months after operation and predictable survival in the medium and long-term: analysis of survival and prognostic markers. World J Surg Oncol 2010; 8: 82.

  • 2.

    Ranjbar R, Saberfar E, Shamsaie A, Ghasemian E. The aetiological role of human papillomavirus in colorectal carcinoma: an Iranian population-based case control study. Asian Pac J Cancer Prev 2014; 15: 1521-1525.

  • 3.

    Abdifard E, Ghaderi S, Hosseini S, Heidari M. Incidence trends of colorectal cancer in the West of Iran during 2000-2005. Asian Pac J Cancer Prev 2013; 14: 1807-1811.

  • 4.

    Dolatkhah R, Somi MH, Kermani IA, Ghojazadeh M, Jafarabadi MA, Farassati F, et al. Increased colorectal cancer incidence in Iran: a systematic review and meta-analysis. B J Cancer Epidemiol 2015; 15: 997. (Persian).

  • 5.

    Ahmadi A, Mosavi-Jarrahi A, Pourhoseingholi MA. Mortality determinants in colorectal cancer patients at different grades: a prospective, cohort study in Iran. Asian Pac J Cancer Prev 2015; 16: 1069.

  • 6.

    Rezaianzadeh A, Safarpour AR, Marzban M, Mohaghegh A. A systematic review over the incidence of colorectal cancer in Iran. Ann Colorectal Res 2015; 3: e25724.

  • 7.

    Kleinbaum DG. Survival Analysis: A Self-learning Text: Springer; 1996.

  • 8.

    Oakes D. The asymptotic information in censored survival data. Biometrika 1977; 64: 441-480.

  • 9.

    Efron B. The efficiency of Cox`s likelihood function for censored data. J Am Stat Assoc 1977; 72: 557-565.

  • 10.

    Park YJ, Park KJ, Park J-G, Lee KU, Choe KJ, Kim J-P. Prognostic factors in 2230 Korean colorectal cancer patients: analysis of consecutively operated cases. World J Surg 1999; 23: 721-726.

  • 11.

    Li XP, Xie ZY, Fu YF, Yang C, Hao LP, Yang LM, et al. Colorectal cancer concealment predicts a poor survival: a retrospective study. Asian Pac J Cancer Prev 2013; 14: 4157-4160.

  • 12.

    Morrison DS, Parr CL, Lam TH, Ueshima H, Kim HC, Jee SH, et al. Behavioural and metabolic risk factors for mortality from colon and rectum cancer: analysis of data from the Asia-pacific cohort studies collaboration. Asian Pac J Cancer Prev 2013; 14: 1083-1087.

  • 13.

    Golfam F, Golfam P, Neghabi Z. Frequency of all types of colorectal tumors in the patients referred to selected hospitals in Tehran. Iranian Red Crescent Med J 2013; 15: 473.

  • 14.

    Siegel R, DeSantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin 2014; 64: 104-117.

  • 15.

    Pourhoseingholi MA, Zali MR. Colorectal cancer screening: Time for action in Iran. World J Gastrointest Oncol 2012; 4: 82-83.

  • 16.

    Bass AJ, Meyerhardt JA, Chan JA, Giovannucci EL, Fuchs CS. Family history and survival after colorectal cancer diagnosis. Cancer 2008; 112: 1222-1229.

  • 17.

    Majek O, Gondos A, Jansen L, Emrich K,Holleczek B, Katalinic A, et al. Sex differences in colorectal cancer survival: population-based analysis of 164,996 colorectal cancer patients in Germany. PLoS One 2013; 8: e68077.

  • 18.

    Safaee A, Fatemi SR, Ashtari S, Vahedi M, Moghimi-Dehkordi B, Zali MR. Four years incidence rate of colorectal cancer in Iran: a survey of national cancer registry dataimplications for screening. Asian Pac J Cancer Prev 2012; 13: 2695-2698.

  • 19.

    Ahmadi A, Mobasheri M, Hashemi Nazari S. Survival time and relative risk of death in patients with colorectal cancer in an Iranian population: a cohort study. J Mazandaran Univ Med Sci 2014; 24: 2-8. (Persian).

  • 20.

    Zhou Z, Ren J, Wan D, Chen G, Lu Z, Pan Z, et al. [Multivariate regressive analysis of prognosis of liver metastases from colorectal cancer]. Ai zheng 2006; 25: 1149-152.

  • 21.

    Moradi A, Khayamzadeh M, Guya MM, Mirzaei HR, Salmanian R, Rakhsha A, et al. Survival of colorectal cancer in Iran. Asian Pac J Cancer Prev 2009; 10: 583-586.

  • 22.

    Caan BJ, Coates AO, Slattery ML, Potter JD, Quesenberry CP Jr, Edwards SM. Body size and the risk of colon cancer in a large case-control study. Int J Obes Relat Metab Disord 1998; 22: 178-184.

  • 23.

    Baghestani AR, Gohari MR, Orooji A, Pourhoseingholi MA, Zali MR. Evaluation of parametric models by the prediction error in colorectal cancer survival analysis. Gastroenterol Hepatol Bed Bench 2015; 8: 183-187.

  • 24.

    Hines RB, Shanmugam C, Waterbor JW, McGwin G, Funkhouser E, Coffey CS, et al. Effect of comorbidity and body mass index on the survival of AfricanAmerican and Caucasian patients with colon cancer. Cancer 2009; 115: 5798-5806.

  • 25.

    Murphy TK, Calle EE, Rodriguez C, Kahn HS, Thun MJ. Body mass index and colon cancer mortality in a large prospective study. Am J Epidemiol 2000; 152: 847-854.

  • 26.

    Nilsen TL, Vatten LJ. Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: exploring the hyperinsulinaemia hypothesis. Br J Cancer 2001; 84: 417.

  • 27.

    Maskarinec G, Harmon BE, Little MA, Ollberding NJ, Kolonel LN, Henderson BE, et al. Excess body weight and colorectal cancer survival: the multiethnic cohort. Cancer Causes Control 2015; 26: 1709-1718.

  • 28.

    Gohari MR, Biglarian A, Bakhshi E, and M. A. Pourhoseingholi, Use of an artificial neural network to determine prognostic factors in colorectal cancer patients, Asian Pacific J Cancer Prev 2011; 12: 1469-1472 (Persian).

  • 29.

    Asghari Jafarabadi M, Mohammadi SM, Hajizadeh E, Fatemi SR. An evulation of 5-year survival of metastatic colon and rectal cancer patients using cumulative incidence models. Koomesh 2013; 14: 207-214 (Persian).

  • 30.

    Akhoond MR, Kazemnejad A, Hajizadeh E, GAnbary Motlagh A, Zali MR. Comparison of influential factors affecting survival of patients with colon and rectum cancer using competing risks model. Koomesh 2011; 12: 119-128 (Persian).

  • 31.

    Baghestani AR, Hajizadeh E. Parametric analysis for interval censored survival data with non-constant shape parameter. JSIAU 2010. (Persian).

  • 32.

    Mazucheli J, Louzada-Neto F, Achcar JA. Lifetime models with nonconstant shape parameters. In press 2003.

  • 33.

    Aghamolaey H, Baghestani AR, Zayeri F. Application of the weibull distribution with a non-constant shape parameter for identifying risk factors in pharyngeal cancer patients. Asian Pac J Cancer Prev 2017; 18: 1537-1542.